{"paper_id":"fe0920cd-cb3a-4159-bce2-a4f024c5c166","body_text":"Abstract\nObjective\nThe aim of the present study was to measure the treatment of menorrhagia and health-related quality of life (QoL) in Levonorgestrel-releasing intrauterine system (LNG-IUS) in Turkish women.\nMaterials and methods\nWe recruited 66 premenopausal women, aged 26–55 years, who had sought care in the previous year for menorrhagia. All patients were asked to complete a visual analog scale (VAS) form regarding pelvic pain, sexual life (libido) and general feeling of health. Patients filled the VAS form before LNG-IUS insertion and after 6 months.\nResults\nAfter the 6-month visit, PBAC score was condirebly decreased (p < 0.001). Six (10%) of the 60 patients PBAC score was higher than 75. VAS score for pelvic pain decreased from baseline to 6-month follow-up (4.32–3.55), and the libido and general feeling of health increased (4.27–4.95 and 3.47–6.87, respectively).\nConclusion\nThe LNG-IUS device in the trearment of menorrhagia has cost effective, less side effects and increse in the QoL.\nSimilar content being viewed by others\nReferences\nHurskainen R, Paavonen J (2004) Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 16:487–490. doi:10.1097/00001703-200412000-00009\nChrisman C, Ribeiro P, Dalton VK (2007) The Levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses. Clin Obstet Gynecol 50(4):886–897\nLethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev CD002126\nHigham JM, O’Brien PMS, Shaw RW (1990) Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97:734–739\nGuyatt GH, Cook DJ (1994) Health status, quality of life, and the individual. JAMA 272(8):630–631. doi:10.1001/jama.272.8.630\nJenkinson C, Peto V, Coulter A (1994) Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia. Qual Life Res 3:317–321. doi:10.1007/BF00451723\nKeshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance—United States, 1994–1999. MMWR CDC Surveill Summ 51:1–8\nClarke A, Black N, Rowe P, Mott S, Howie K (1995) Indications for and outcomes of total abdominal hysterectomy for benign disease; a prospective cohort study. Br J Obstet Gynaecol 102:611–620\nDwyer N, Hutton J, Stirrat GM (1993) Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorraghia. Br J Obstet Gynaecol 100:237–243\nSculpher MJ, Dwyer N, Byford S, Stirrat GM (1996) Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 103:142–149\nHurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A et al (2001) Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357:273–277. doi:10.1016/S0140-6736(00)03615-1\nCoulter A, Peto V, Jenkinson C (1994) Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 11:394–401. doi:10.1093/fampra/11.4.394\nShankar M, Kadir RA (2008) Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 14:15–20\nMyers ER, Steege JF (1999) Risk adjustment for complications of hysterectomy: limitations of routinely collected administrative data. Am J Obstet Gynecol 181:567–575. doi:10.1016/S0002-9378(99)70494-1\nInki P (2007) Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75:161–166. doi:10.1016/j.contraception.2006.12.016\nNational Collaborating Centre for Women’s and Children’s Health (NICE) Heavy menstrual bleeding. Published by the RCOG Press at the Royal Collage of Obstetricians and Gynaecologists, London. www.rcog.org.uk\nHurskainen R (2006) Managing drug-resistant essential menorrhagia without hysterectomy. Best Pract Res Clin Obstet Gynaecol 20(5):681–694. doi:10.1016/j.bpobgyn.2006.03.003\nBourdrez P, Bongers MY, Mol BWJ (2004) Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrelreleasing intrauterine device, or hysterectomy. Fertil Steril 82:160–166. doi:10.1016/j.fertnstert.2003.12.025\nVuorma S, Teperi J, Hurskainen R, Aalto AM, Rissanen P, Kujansuu E (2003) Correlates of women’s preferences for treatment of heavy menstrual bleeding. Patient Educ Couns 49(2):125–132. doi:10.1016/S0738-3991(02)00069-1\nGuyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118(8):622–629\nConflict of interest statement\nThe authors stated that they had no interests which might be perceived as posing a conflict or bias.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nGorgen, H., Api, M., Akça, A. et al. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet 279, 835–840 (2009). https://doi.org/10.1007/s00404-008-0834-x\nReceived:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-008-0834-x","source_license":"CC0","license_restricted":false}